BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,743,323 | -21.1% | 654,608 | +4.7% | 0.00% | -25.0% |
| Q2 2023 | $19,955,036 | +7.2% | 624,962 | +2.8% | 0.00% | 0.0% |
| Q1 2023 | $18,615,857 | -22.3% | 607,964 | -0.8% | 0.00% | -20.0% |
| Q4 2022 | $23,968,563 | -16.8% | 612,850 | +1.4% | 0.01% | -28.6% |
| Q3 2022 | $28,796,000 | +32.3% | 604,440 | +7.5% | 0.01% | +40.0% |
| Q2 2022 | $21,759,000 | -17.6% | 562,103 | +21.9% | 0.01% | 0.0% |
| Q1 2022 | $26,418,000 | -30.9% | 461,043 | -3.9% | 0.01% | -16.7% |
| Q4 2021 | $38,247,000 | -8.2% | 479,958 | +0.2% | 0.01% | -14.3% |
| Q3 2021 | $41,669,000 | -28.6% | 478,897 | +5.6% | 0.01% | -30.0% |
| Q2 2021 | $58,379,000 | +81.1% | 453,574 | +12.6% | 0.01% | +66.7% |
| Q1 2021 | $32,236,000 | -7.6% | 402,757 | -5.7% | 0.01% | -14.3% |
| Q4 2020 | $34,873,000 | +270.8% | 427,157 | +11.8% | 0.01% | +250.0% |
| Q3 2020 | $9,406,000 | +100.9% | 382,056 | +128.4% | 0.00% | +100.0% |
| Q2 2020 | $4,682,000 | +98.6% | 167,243 | +27.6% | 0.00% | 0.0% |
| Q1 2020 | $2,358,000 | – | 131,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |